SunHydrogen Reports Improved Net Loss of $1.5 Million for Quarter Ended March 31, 2026

SunHydrogen, Inc. reported its financial results for the three and nine months ended March 31, 2026, revealing a net loss of $1.5 million for the quarter, a slight improvement from a loss of $1.7 million in the same period last year. For the nine-month period, the company recorded a net loss of $4.6 million, down from $7.3 million in the prior year. The company generated minimal revenue of $1,250 during the nine months, compared to no revenue in the same period last year. Operating expenses decreased to $1.7 million for the quarter, down from $2.1 million, primarily due to reduced research and development costs and general administrative expenses.

The company’s total assets decreased to approximately $33.9 million as of March 31, 2026, from $37.9 million at the end of the previous fiscal year. This decline was largely attributed to a significant reduction in cash and cash equivalents, which fell to $13.1 million from $34.6 million. The decrease in cash was influenced by cash used in operating activities amounting to $3.9 million for the nine months, an increase from $3.0 million in the prior year. The company also reported a notable increase in short-term investments, which rose to $19.8 million from $3.0 million, reflecting strategic investment decisions.

In terms of operational developments, SunHydrogen has been focusing on its core mission of developing a solar-powered nanoparticle system for hydrogen production. The company is also exploring a new methodology that utilizes thin-film solar cells to enhance hydrogen production efficiency. As of March 31, 2026, the company had 5.7 billion shares of common stock outstanding, an increase from 5.4 billion shares a year earlier, reflecting ongoing capital-raising efforts. The company’s employee headcount remains stable, supporting its research and development initiatives.

Looking ahead, SunHydrogen's management emphasized the importance of raising capital to support its operations and technology development. The company has historically relied on private placements and registered offerings to meet its funding needs. Management expressed optimism about its ability to continue raising funds through the sale of securities, although it acknowledged the inherent risks and uncertainties associated with capital-raising efforts. The company remains committed to its goal of providing a cost-effective solution for renewable hydrogen production, which it believes is essential for reducing reliance on fossil fuels.